AI assistant
Sending…
Terns Pharmaceuticals, Inc. — Director's Dealing 2021
Feb 4, 2021
32559_dirs_2021-02-04_8ea752dd-de66-413c-9f89-62832b1de5bd.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Terns Pharmaceuticals, Inc. (TERN)
CIK: 0001831363
Period of Report: 2021-02-04
Reporting Person: Lu Hongbo (Director)